Sakitamiwa Classification 【FREE — 2027】

This group includes children where the infection has spread beyond the lungs to other organ systems.

The application process involves a multi-step diagnostic workflow:

Why does the Sakitamiwa classification persist?

Why is this classification important in clinical practice?

Prognostic Value:

Differential Diagnosis: It helps pediatricians distinguish between localized infection which may resolve spontaneously or with minimal intervention, versus systemic disease requiring aggressive therapy.

Let us develop a hypothetical case study to illustrate the classification.

The Treatment Protocol: In the Sakitamiwa classification, antibiotics are secondary. The primary treatment involves the "healer" or elder facilitating a ritual to reverse the spiritual transgression. The success of this treatment reinforces the validity of the classification within the community.

If you want, I can:

The Sakita-Miwa classification is a standardized medical staging system used primarily in East Asian clinical practice to evaluate the healing process of gastric and duodenal ulcers. It breaks down the "life cycle" of an ulcer into six distinct stages categorized under three main phases: Active, Healing, and Scarring. Active Phase (A)

This is the initial stage where the ulcer is fully formed and "open." sakitamiwa classification

A1 (Active 1): The ulcer is at its peak. The surrounding mucosa (lining) is swollen and red, and the ulcer floor is covered with a thick "white coating" (slough).

A2 (Active 2): The swelling around the edges begins to subside, but the white coating remains thick and the ulcer crater is still very distinct. Healing Phase (H)

In this phase, the body begins to repair the damage and "fill in" the crater.

H1 (Healing 1): The ulcer crater is still visible, but the margins become sharper and the diameter of the defect shrinks to about half or two-thirds of the A1 stage. Regenerating epithelium (new skin) starts appearing at the edges.

H2 (Healing 2): The defect becomes much smaller. New regenerating epithelium covers most of the ulcer floor, though a small white coating may still be visible. Scarring Phase (S)

This is the final stage where the ulcer has effectively closed.

S1 (Scarring 1/Red Scar): The white coating has completely disappeared, and new epithelium fully covers the floor. Because the new tissue is thin and has many blood vessels, it appears as a "red scar".

S2 (Scarring 2/White Scar): Over several months to years, the redness fades. The scar becomes the same color as the surrounding tissue, often appearing as a "white scar". This group includes children where the infection has

💡 Clinical SignificanceDoctors use this system to determine if a treatment—like proton pump inhibitors (PPIs)—is working. An ulcer is medically considered "cured" once it reaches the S1 or S2 stage.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

The Sakita-Miwa classification is a standard endoscopic staging system used to evaluate the healing process of gastric and duodenal ulcers. It divides ulcer progression into three main stages (Active, Healing, and Scarring), with each further subdivided into two levels. Classification Stages The system uses the following six-stage categorical scale: Stage Description A1 Acute phase; thick white coating (slough) and sharp edges. A2

Slough becomes thinner; regenerative epithelium begins to appear. H1

Significant reduction in slough; clear signs of marginal regeneration. H2 Ulcer becomes very small; slough is nearly gone. S1 Scarring 1 Red scar; the white coating has completely disappeared. S2 Scarring 2

White scar; the lesion is completely healed and mucosal folds normalize. Relevant Papers

The classification was originally established in the early 1970s. While the original primary text is often cited as a textbook or early Japanese journal entry, you can find the classification detailed and applied in these authoritative research papers:

Original/Reference Source: Sakita T, et al. "Endoscopic diagnosis of ulcer—Classification of the ulcer stage." Japan Journal of Gastroenterology (1971). Prognostic Value:

Modern Application: The value of oral contrast-enhanced gastric ultrasonography (OCUS) in the staging of benign peptic ulcer (BPU) published in Nature Scientific Reports (2024).

Clinical Efficacy Study: Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients published in Digestive Diseases (2011).

Comparative Trial: Randomised clinical trial: tegoprazan or lansoprazole in the treatment of gastric ulcer in Alimentary Pharmacology & Therapeutics (2020).

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

However, "Sakitamiwa" is not a standard term in modern Western medical literature (ICD-10 or ICD-11). It is most likely a folk illness concept or a traditional classification of symptoms.

Below is a developed academic paper proposal structured to explore this topic. This paper treats "Sakitamiwa" as a Folk Illness Syndrome, analyzing it through the lenses of medical anthropology and ethnomedicine.

Title: Beyond the Biomedical: An Ethnomedical Analysis of 'Sakitamiwa' Classification and its Socio-Cultural Determinants

Abstract This paper investigates the classification of "Sakitamiwa," a term rooted in local indigenous medical systems, often referenced in Southeast Asian ethnomedicine. While modern biomedicine categorizes illness based on pathology and etiology, folk classifications like Sakitamiwa rely on symptom clusters, social context, and spiritual etiology. This study aims to deconstruct the Sakitamiwa classification, comparing its nosology with Western biomedical frameworks. By analyzing the symptomatic presentation and traditional healing rituals associated with Sakitamiwa, this paper argues that such classifications serve as crucial cultural coping mechanisms, offering a holistic framework that addresses the biological, psychological, and social well-being of the patient.

To understand Sakitamiwa, one must adopt an emic perspective (the insider's view) rather than the etic perspective (the outsider/scientific view).